GrippeAllemagneV3, Main, Exploration, bibRecord, 000501

Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.

Identifieur interne : 000501 ( Main/Exploration ); précédent : 000500; suivant : 000502

Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.

Auteurs : Birgit Ehlken [Allemagne] ; Gabriele Ihorst ; Barbara Lippert ; Angela Rohwedder ; Gudula Petersen ; Martin Schumacher ; Johannes Forster

Source :

European journal of pediatrics [ 0340-6199 ] ; 2005.

RBID : pubmed:15965766

Descripteurs français

English descriptors

Abstract

Data on the economic burden of lower respiratory tract infections (LRTI) in young children are lacking in Germany. The objective of the cost-of-illness study was to estimate the economic impact of community-acquired LRTI and nosocomial LRTI as well as of infections due to respiratory syncytial virus (RSV), parainfluenza viruses (PIV) and influenza viruses (IV). The economic analysis is part of the PRIDE study, a prospective, multi-centre, population-based epidemiological study on the impact of LRTI in children aged 0 to 36 months in Germany. The analysis includes children with community-acquired infections (1329 cases treated as outpatients, 2039 cases treated as inpatients) and nosocomial infections (90 cases). Medical services consumed were generated by chart abstraction and parental expenses data by telephone interviews within four weeks after physician visit or hospitalisation. Costs were evaluated from following perspectives: third party payer, parent and society. Total costs for outpatient treatment are Euro 123 per LRTI case. Stratified by virus type, total costs per case are Euro 163 (RSV), Euro 100 (PIV) and Euro 223 (IV). Total costs per hospitalised LRTI case amount to Euro 2579. Stratified by virus type, total costs per case are Euro 2772 (RSV), Euro 2374 (PIV) and Euro 2597 (IV). Total costs per nosocomial case are Euro 2814. Economic burden due to LRTI is Euro 213 million annually. It is concluded that treatment of LRTI in children up to age three causes a considerable economic burden in Germany. Presented results are the first data describing the economic burden of LRTI in young children assessed by means of the incidence data for Germany. This cost-of-illness study provides basic data for further decision-making, focusing on the economic assessment of preventive strategies for RSV, PIV and IV infections.

DOI: 10.1007/s00431-005-1705-0
PubMed: 15965766

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000510
to stream Main, to step Curation: 000510

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.</title>
<author><name sortKey="Ehlken, Birgit" sort="Ehlken, Birgit" uniqKey="Ehlken B" first="Birgit" last="Ehlken">Birgit Ehlken</name>
<affiliation wicri:level="3"><nlm:affiliation>MERG, Medical Economics Research Group, Munich, Germany. birgit.ehlken@merg-munich.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>MERG, Medical Economics Research Group, Munich</wicri:regionArea>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ihorst, Gabriele" sort="Ihorst, Gabriele" uniqKey="Ihorst G" first="Gabriele" last="Ihorst">Gabriele Ihorst</name>
</author>
<author><name sortKey="Lippert, Barbara" sort="Lippert, Barbara" uniqKey="Lippert B" first="Barbara" last="Lippert">Barbara Lippert</name>
</author>
<author><name sortKey="Rohwedder, Angela" sort="Rohwedder, Angela" uniqKey="Rohwedder A" first="Angela" last="Rohwedder">Angela Rohwedder</name>
</author>
<author><name sortKey="Petersen, Gudula" sort="Petersen, Gudula" uniqKey="Petersen G" first="Gudula" last="Petersen">Gudula Petersen</name>
</author>
<author><name sortKey="Schumacher, Martin" sort="Schumacher, Martin" uniqKey="Schumacher M" first="Martin" last="Schumacher">Martin Schumacher</name>
</author>
<author><name sortKey="Forster, Johannes" sort="Forster, Johannes" uniqKey="Forster J" first="Johannes" last="Forster">Johannes Forster</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15965766</idno>
<idno type="pmid">15965766</idno>
<idno type="doi">10.1007/s00431-005-1705-0</idno>
<idno type="wicri:Area/Main/Corpus">000510</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000510</idno>
<idno type="wicri:Area/Main/Curation">000510</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000510</idno>
<idno type="wicri:Area/Main/Exploration">000510</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.</title>
<author><name sortKey="Ehlken, Birgit" sort="Ehlken, Birgit" uniqKey="Ehlken B" first="Birgit" last="Ehlken">Birgit Ehlken</name>
<affiliation wicri:level="3"><nlm:affiliation>MERG, Medical Economics Research Group, Munich, Germany. birgit.ehlken@merg-munich.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>MERG, Medical Economics Research Group, Munich</wicri:regionArea>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ihorst, Gabriele" sort="Ihorst, Gabriele" uniqKey="Ihorst G" first="Gabriele" last="Ihorst">Gabriele Ihorst</name>
</author>
<author><name sortKey="Lippert, Barbara" sort="Lippert, Barbara" uniqKey="Lippert B" first="Barbara" last="Lippert">Barbara Lippert</name>
</author>
<author><name sortKey="Rohwedder, Angela" sort="Rohwedder, Angela" uniqKey="Rohwedder A" first="Angela" last="Rohwedder">Angela Rohwedder</name>
</author>
<author><name sortKey="Petersen, Gudula" sort="Petersen, Gudula" uniqKey="Petersen G" first="Gudula" last="Petersen">Gudula Petersen</name>
</author>
<author><name sortKey="Schumacher, Martin" sort="Schumacher, Martin" uniqKey="Schumacher M" first="Martin" last="Schumacher">Martin Schumacher</name>
</author>
<author><name sortKey="Forster, Johannes" sort="Forster, Johannes" uniqKey="Forster J" first="Johannes" last="Forster">Johannes Forster</name>
</author>
</analytic>
<series><title level="j">European journal of pediatrics</title>
<idno type="ISSN">0340-6199</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age Distribution</term>
<term>Ambulatory Care (economics)</term>
<term>Child, Preschool</term>
<term>Community-Acquired Infections (economics)</term>
<term>Community-Acquired Infections (epidemiology)</term>
<term>Cost of Illness</term>
<term>Cross Infection (economics)</term>
<term>Cross Infection (epidemiology)</term>
<term>Female</term>
<term>Germany (epidemiology)</term>
<term>Health Care Costs</term>
<term>Hospitalization (economics)</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Insurance, Health, Reimbursement (economics)</term>
<term>Male</term>
<term>Orthomyxoviridae Infections (economics)</term>
<term>Orthomyxoviridae Infections (epidemiology)</term>
<term>Paramyxoviridae Infections (economics)</term>
<term>Paramyxoviridae Infections (epidemiology)</term>
<term>Prospective Studies</term>
<term>Respiratory Syncytial Virus Infections (economics)</term>
<term>Respiratory Syncytial Virus Infections (epidemiology)</term>
<term>Respiratory Tract Infections (economics)</term>
<term>Respiratory Tract Infections (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Allemagne (épidémiologie)</term>
<term>Coût de la maladie</term>
<term>Coûts des soins de santé</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Hospitalisation (économie)</term>
<term>Humains</term>
<term>Infection croisée (économie)</term>
<term>Infection croisée (épidémiologie)</term>
<term>Infections communautaires (économie)</term>
<term>Infections communautaires (épidémiologie)</term>
<term>Infections de l'appareil respiratoire (économie)</term>
<term>Infections de l'appareil respiratoire (épidémiologie)</term>
<term>Infections à Orthomyxoviridae (économie)</term>
<term>Infections à Orthomyxoviridae (épidémiologie)</term>
<term>Infections à Paramyxoviridae (économie)</term>
<term>Infections à Paramyxoviridae (épidémiologie)</term>
<term>Infections à virus respiratoire syncytial (économie)</term>
<term>Infections à virus respiratoire syncytial (épidémiologie)</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Remboursement par l'assurance maladie (économie)</term>
<term>Répartition par âge</term>
<term>Soins ambulatoires (économie)</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Ambulatory Care</term>
<term>Community-Acquired Infections</term>
<term>Cross Infection</term>
<term>Hospitalization</term>
<term>Insurance, Health, Reimbursement</term>
<term>Orthomyxoviridae Infections</term>
<term>Paramyxoviridae Infections</term>
<term>Respiratory Syncytial Virus Infections</term>
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Community-Acquired Infections</term>
<term>Cross Infection</term>
<term>Orthomyxoviridae Infections</term>
<term>Paramyxoviridae Infections</term>
<term>Respiratory Syncytial Virus Infections</term>
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Hospitalisation</term>
<term>Infection croisée</term>
<term>Infections communautaires</term>
<term>Infections de l'appareil respiratoire</term>
<term>Infections à Orthomyxoviridae</term>
<term>Infections à Paramyxoviridae</term>
<term>Infections à virus respiratoire syncytial</term>
<term>Remboursement par l'assurance maladie</term>
<term>Soins ambulatoires</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term>
<term>Infection croisée</term>
<term>Infections communautaires</term>
<term>Infections de l'appareil respiratoire</term>
<term>Infections à Orthomyxoviridae</term>
<term>Infections à Paramyxoviridae</term>
<term>Infections à virus respiratoire syncytial</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Age Distribution</term>
<term>Child, Preschool</term>
<term>Cost of Illness</term>
<term>Female</term>
<term>Health Care Costs</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Prospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Coût de la maladie</term>
<term>Coûts des soins de santé</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Répartition par âge</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Data on the economic burden of lower respiratory tract infections (LRTI) in young children are lacking in Germany. The objective of the cost-of-illness study was to estimate the economic impact of community-acquired LRTI and nosocomial LRTI as well as of infections due to respiratory syncytial virus (RSV), parainfluenza viruses (PIV) and influenza viruses (IV). The economic analysis is part of the PRIDE study, a prospective, multi-centre, population-based epidemiological study on the impact of LRTI in children aged 0 to 36 months in Germany. The analysis includes children with community-acquired infections (1329 cases treated as outpatients, 2039 cases treated as inpatients) and nosocomial infections (90 cases). Medical services consumed were generated by chart abstraction and parental expenses data by telephone interviews within four weeks after physician visit or hospitalisation. Costs were evaluated from following perspectives: third party payer, parent and society. Total costs for outpatient treatment are Euro 123 per LRTI case. Stratified by virus type, total costs per case are Euro 163 (RSV), Euro 100 (PIV) and Euro 223 (IV). Total costs per hospitalised LRTI case amount to Euro 2579. Stratified by virus type, total costs per case are Euro 2772 (RSV), Euro 2374 (PIV) and Euro 2597 (IV). Total costs per nosocomial case are Euro 2814. Economic burden due to LRTI is Euro 213 million annually. It is concluded that treatment of LRTI in children up to age three causes a considerable economic burden in Germany. Presented results are the first data describing the economic burden of LRTI in young children assessed by means of the incidence data for Germany. This cost-of-illness study provides basic data for further decision-making, focusing on the economic assessment of preventive strategies for RSV, PIV and IV infections.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15965766</PMID>
<DateCompleted><Year>2006</Year>
<Month>05</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0340-6199</ISSN>
<JournalIssue CitedMedium="Print"><Volume>164</Volume>
<Issue>10</Issue>
<PubDate><Year>2005</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>European journal of pediatrics</Title>
<ISOAbbreviation>Eur. J. Pediatr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.</ArticleTitle>
<Pagination><MedlinePgn>607-15</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Data on the economic burden of lower respiratory tract infections (LRTI) in young children are lacking in Germany. The objective of the cost-of-illness study was to estimate the economic impact of community-acquired LRTI and nosocomial LRTI as well as of infections due to respiratory syncytial virus (RSV), parainfluenza viruses (PIV) and influenza viruses (IV). The economic analysis is part of the PRIDE study, a prospective, multi-centre, population-based epidemiological study on the impact of LRTI in children aged 0 to 36 months in Germany. The analysis includes children with community-acquired infections (1329 cases treated as outpatients, 2039 cases treated as inpatients) and nosocomial infections (90 cases). Medical services consumed were generated by chart abstraction and parental expenses data by telephone interviews within four weeks after physician visit or hospitalisation. Costs were evaluated from following perspectives: third party payer, parent and society. Total costs for outpatient treatment are Euro 123 per LRTI case. Stratified by virus type, total costs per case are Euro 163 (RSV), Euro 100 (PIV) and Euro 223 (IV). Total costs per hospitalised LRTI case amount to Euro 2579. Stratified by virus type, total costs per case are Euro 2772 (RSV), Euro 2374 (PIV) and Euro 2597 (IV). Total costs per nosocomial case are Euro 2814. Economic burden due to LRTI is Euro 213 million annually. It is concluded that treatment of LRTI in children up to age three causes a considerable economic burden in Germany. Presented results are the first data describing the economic burden of LRTI in young children assessed by means of the incidence data for Germany. This cost-of-illness study provides basic data for further decision-making, focusing on the economic assessment of preventive strategies for RSV, PIV and IV infections.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ehlken</LastName>
<ForeName>Birgit</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>MERG, Medical Economics Research Group, Munich, Germany. birgit.ehlken@merg-munich.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ihorst</LastName>
<ForeName>Gabriele</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lippert</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rohwedder</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Petersen</LastName>
<ForeName>Gudula</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Schumacher</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Forster</LastName>
<ForeName>Johannes</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><CollectiveName>PRIDE Study Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2005</Year>
<Month>06</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Eur J Pediatr</MedlineTA>
<NlmUniqueID>7603873</NlmUniqueID>
<ISSNLinking>0340-6199</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000553" MajorTopicYN="N">Ambulatory Care</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017281" MajorTopicYN="Y">Cost of Illness</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017048" MajorTopicYN="N">Health Care Costs</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007349" MajorTopicYN="N">Insurance, Health, Reimbursement</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018184" MajorTopicYN="N">Paramyxoviridae Infections</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018357" MajorTopicYN="N">Respiratory Syncytial Virus Infections</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year>
<Month>01</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2005</Year>
<Month>05</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2005</Year>
<Month>05</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>6</Month>
<Day>21</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>5</Month>
<Day>19</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>6</Month>
<Day>21</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15965766</ArticleId>
<ArticleId IdType="doi">10.1007/s00431-005-1705-0</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Vaccine. 2002 Jun 7;20(19-20):2562-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12057614</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1997 Apr;175(4):807-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9086134</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemiol Infect. 2002 Dec;129(3):525-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12558335</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pediatr. 2003 Apr;162(4):237-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12647196</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pediatr. 2004 Dec;163(12):709-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15372233</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 1991 Sep;88(3):527-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1881733</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Inf Med. 2004;43(5):479-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15702205</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2000 Jan 27;342(4):225-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10648763</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Dis Child. 1986 Jun;140(6):543-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3706232</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 1997 Jan;99(1):93-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8989345</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Ther. 1999 Apr;21(4):752-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10363740</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1991 Apr;163(4):687-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2010623</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 2004 Jun;23(6):523-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15194833</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Dis Child. 2003 Dec;88(12):1065-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14670770</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Klin Padiatr. 2004 Jan-Feb;216(1):7-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14747964</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Dis Child. 2001 Dec;85(6):463-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11719328</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 1988 Aug;82(2):199-203</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3399292</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pediatr. 1998 Mar;157(3):215-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9537488</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Klin Padiatr. 2002 Nov-Dec;214(6):334-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12424681</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 2001 Feb;20(2):160-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11224834</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Pediatr Adolesc Med. 2000 Jan;154(1):55-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10632251</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Bavière</li>
<li>District de Haute-Bavière</li>
</region>
<settlement><li>Munich</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Forster, Johannes" sort="Forster, Johannes" uniqKey="Forster J" first="Johannes" last="Forster">Johannes Forster</name>
<name sortKey="Ihorst, Gabriele" sort="Ihorst, Gabriele" uniqKey="Ihorst G" first="Gabriele" last="Ihorst">Gabriele Ihorst</name>
<name sortKey="Lippert, Barbara" sort="Lippert, Barbara" uniqKey="Lippert B" first="Barbara" last="Lippert">Barbara Lippert</name>
<name sortKey="Petersen, Gudula" sort="Petersen, Gudula" uniqKey="Petersen G" first="Gudula" last="Petersen">Gudula Petersen</name>
<name sortKey="Rohwedder, Angela" sort="Rohwedder, Angela" uniqKey="Rohwedder A" first="Angela" last="Rohwedder">Angela Rohwedder</name>
<name sortKey="Schumacher, Martin" sort="Schumacher, Martin" uniqKey="Schumacher M" first="Martin" last="Schumacher">Martin Schumacher</name>
</noCountry>
<country name="Allemagne"><region name="Bavière"><name sortKey="Ehlken, Birgit" sort="Ehlken, Birgit" uniqKey="Ehlken B" first="Birgit" last="Ehlken">Birgit Ehlken</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000501 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000501 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeAllemagneV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:15965766
   |texte=   Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:15965766" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeAllemagneV3

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 11:47:10 2020. Site generation: Sat Sep 26 09:55:33 2020

	Corpus GrippeAllemagneV3
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus GrippeAllemagneV3

Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.

Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki